![]() |
市场调查报告书
商品编码
1880649
多股/编织可吸收缝合线市场规模、占有率、成长及全球产业分析:依类型、应用和地区划分的洞察与预测(2024-2032)Multifilament/Braided Absorbable Sutures Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032 |
||||||
全球多股/编织可吸收缝合线市场持续稳定成长,主要受外科领域对先进伤口闭合解决方案需求不断增长的推动。根据近期一份报告,受慢性病发病率上升和全球外科手术数量增加的推动,该市场规模预计在2024年达到30.4亿美元。预计2025年,市场规模将扩大至32亿美元,2032年将达到55.1亿美元,预测期内复合年增长率(CAGR)为8.0%。
多股或编织可吸收缝合线由加捻或编织的纤维製成,设计用于在体内逐渐溶解。其优异的抗拉强度、柔韧性和牢固的打结性能使其成为内部外科手术的理想选择,尤其适用于难以拆线的手术。随着全球外科手术数量的增加,对这类缝线的需求持续成长。
市场推动因素
全球外科手术数量的显着成长正在推动市场成长。骨科、妇科、整形外科和心血管外科等领域越来越依赖可吸收缝线来促进伤口更快癒合并减轻患者不适。例如,根据国际美容整形外科学会 (ISAPS) 的数据,2022 年全球鼻整形手术数量约为 90 万例,预计 2023 年将增至 110 万例。同样,英国剖腹产率预计将从 2022 年的 34.7% 增加到 2023 年的 37.8%,这将推动外科缝线需求的成长。
老年人口不断增长,他们易患慢性疾病,需要频繁接受手术治疗,这进一步推动了市场成长。 DemeTECH Corporation、强生服务公司、美敦力公司和贝朗公司等主要公司推出的新产品也增强了全球市场的产品供应。
市场限制因子
儘管需求不断增长,但由于其他伤口闭合方法的日益普及,市场仍面临挑战。由于手术缝合器、组织黏合剂、止血钳和胶带具有诸多优势,例如缝合速度更快、疤痕更少、组织损伤最小,因此在某些手术中越来越受欢迎。例如,根据 Suture Planet 发布的 2025 年报告,与缝线相比,手术缝合器能够实现更快、更牢固的缝合,尤其是在骨科和开放性手术中。
这种向替代方法的转变限制了多股/编织缝线的应用,尤其是在医疗体系发达的地区。此外,缝线感染、结节裂开、疤痕形成和组织反应等术后併发症仍然是外科医生关注的重点。
市场机会
发展中国家医疗基础设施的不断改善带来了巨大的市场机会。随着亚太地区、拉丁美洲和非洲新医院和手术中心的不断涌现,手术总量持续成长。例如,位于新南威尔斯州的格里菲斯基地医院将于 2025 年 6 月开业,这标誌着支持外科手术护理的基础设施得到了扩展。
抗菌涂层缝线、合成生物工程材料和无结可吸收缝合线等技术进步也为成长开闢了新的途径。这些创新正在改善组织癒合、降低感染风险并简化手术流程。
市场挑战
监管的复杂性仍然是製造商面临的主要挑战。美国 FDA、EMA 和其他监管机构实施的审批流程需要大量的临床数据,这增加了研发成本并延迟了市场准入,尤其对于中小企业而言更是如此。监管要求的区域差异也使全球市场扩张变得更加复杂。
北美在 2024 年引领全球市场,占全球市场的 42.76%,市场规模达 13 亿美元。强大的医疗基础设施、高手术量和充足的产品供应支撑了该地区的领先地位。
欧洲将维持适中的市场占有率,这得益于手术量的成长趋势,例如德国在2023年进行了100,606例心臟手术。
由于医疗设施的扩张、新产品的推出以及医疗旅游业的蓬勃发展,亚太地区预计将以最高的复合年增长率增长。 Healthium Medtech公司于2023年推出的TRUMAS缝合线便是该地区创新发展的典型例证。
拉丁美洲和中东/非洲地区预计将保持稳定成长,这主要得益于一般外科、骨科、眼科和心臟护理手术量的成长。
The global multifilament/braided absorbable sutures market continues to grow steadily as demand for advanced wound-closure solutions rises across surgical disciplines. According to the latest report, the market was valued at USD 3.04 billion in 2024, driven by an increasing burden of chronic diseases and a higher volume of surgical procedures worldwide. The market is expected to expand to USD 3.20 billion in 2025 and further reach USD 5.51 billion by 2032, registering a strong CAGR of 8.0% during the forecast period.
Multifilament or braided absorbable sutures are made from twisted or braided strands designed to dissolve inside the body over time. Their superior tensile strength, flexibility, and secure knotting capacity make them ideal for internal surgical procedures, particularly where suture removal is not feasible. As global surgical volumes rise, demand for these sutures continues to accelerate.
Market Drivers
A significant rise in surgical procedures worldwide is driving market growth. Surgeries such as orthopedic, gynecological, cosmetic, and cardiovascular interventions rely heavily on absorbable sutures to promote rapid healing and reduce patient discomfort. For example, around 0.9 million rhinoplasty procedures were performed worldwide in 2022, increasing to 1.1 million in 2023, according to the International Society of Aesthetic Plastic Surgery. Similarly, caesarean deliveries in the U.K. increased from 34.7% in 2022 to 37.8% in 2023, contributing to rising demand for surgical sutures.
An expanding geriatric population, more prone to chronic illness and requiring frequent surgical care, further supports market growth. New product launches by leading players such as DemeTECH Corporation, Johnson & Johnson Services, Inc., Medtronic, and B. Braun SE also strengthen product availability across global markets.
Market Restraints
Despite growing demand, the market faces challenges due to rising adoption of alternative wound-closure methods. Surgical staplers, tissue adhesives, hemostats, and adhesive tapes are increasingly preferred in certain procedures due to benefits such as faster closure, reduced scarring, and minimized tissue trauma. For instance, according to Suture Planet's 2025 report, surgical staplers enable quicker and more secure closure compared to sutures, particularly in orthopedic and laparotomy surgeries.
This shift toward alternatives limits the adoption of multifilament/braided sutures, especially in regions with advanced healthcare systems. Additionally, postoperative complications such as suture infections, knot failures, scarring, and tissue reactions remain significant concerns among surgeons.
Market Opportunities
Expanding healthcare infrastructure in developing countries offers significant market opportunities. As new hospitals and surgical centers open across Asia Pacific, Latin America, and Africa, the overall number of surgical procedures continues to rise. For instance, Griffith Base Hospital opened in New South Wales in June 2025, illustrating the expanding infrastructure supporting surgical care.
Technological advancements-such as antimicrobial-coated sutures, synthetic bioengineered materials, and knotless absorbable sutures-are also creating new growth avenues. These innovations improve tissue healing, reduce infection risk, and simplify surgical workflows.
Market Challenges
Regulatory complexities remain a major challenge for manufacturers. Approval processes enforced by the U.S. FDA, EMA, and other regulatory bodies require extensive clinical data, increasing development costs and delaying market entry-particularly for small and mid-sized companies. Differences in regulatory requirements across regions further complicate global market expansion.
North America dominated the global market in 2024 with a market size of USD 1.30 billion, accounting for 42.76% of global share. Strong healthcare infrastructure, high surgical volumes, and extensive product availability fuel regional dominance.
Europe holds a moderate share, supported by rising surgical procedures such as the 100,606 cardiac surgeries performed in Germany in 2023.
Asia Pacific is expected to grow at the fastest CAGR due to expanding healthcare facilities, new product launches, and increasing medical tourism. Healthium Medtech's launch of TRUMAS sutures in 2023 highlights the region's growing innovation landscape.
Latin America and the Middle East & Africa will experience steady growth, supported by rising surgical volumes in general, orthopedic, ophthalmic, and cardiac care.
Conclusion
Projected to grow from USD 3.04 billion in 2024 to USD 5.51 billion by 2032, the multifilament/braided absorbable sutures market is set for robust expansion. Increasing surgical procedures, technological innovation, and expanding healthcare infrastructure will remain key drivers, despite challenges from alternative wound-closure methods and regulatory complexities.
Segmentation By Type, Application, End-user, and Region
By Type * Natural
By Application * Gynecology
By End-user * Hospitals & ASCs
By Region * North America (By Type, by Application, by End-user, and by Country)
U.S.
Canada
Germany
U.K.
France
Italy
Spain
Scandinavia
Rest of Europe
China
Japan
India
Australia
Southeast Asia
Rest of Asia Pacific
Brazil
Mexico
Rest of Latin America
GCC
South Africa
Rest of the Middle East & Africa